Marijuana has long been known to increase appetite, and the selective cannabinoid CB1 receptor antagonist SR141716A has been recently reported to decrease food intake in rodents. We took advantage of mice deficient in CB1 receptors (CB1-/- mice) and their wild-type controls (CB1+/+ mice) to examine the possible involvement of endogenous cannabinoids in the physiologial regulation of food intake. In animals with unrestricted access to food, food intake was similar in CB1-/- and CB1+/+ mice. Brief food deprivation increased food intake significantly more in CB1+/+ than in CB1-/-mice, and pretreatment of such mice with SR141716A reduced food intake in wild-type but not in Cb1-/- mice. These findings indicate a role of endocannabinoids acting at CB1 receptors in the hunger-induced increase in food intake. Adipocyte-derived leptin is the primary signal through which the brain senses nutritional status. Leptin regulates energy expenditure and food intake by upregulating anorexigenic hormones, such as a-MSH, and downregulating orexigenic hormones, such as NPY, in the hypothalamus. Acute treatment of rats with leptin reduced hypothalamic, but not cerebellar, levels of the endocannabinoids anandamide (AEA) and 2-arachidonoyl glycerol (2-AG), whereas hypothalamic AEA and 2-AG were increased in genetically obese animals with defective leptin signaling. Furthermore, chronic treatment of obese db/db mice with SR141716A reduced food intake as well as weight gain. These findings indicate that hypothalamic endocannabinoids are under the negative regulatory influence of leptin, and they may contribute to the hyperphagia and obesity in animals with defective leptin signaling.

Agency
National Institute of Health (NIH)
Institute
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Type
Intramural Research (Z01)
Project #
1Z01AA000350-01
Application #
6542039
Study Section
(LPS)
Project Start
Project End
Budget Start
Budget End
Support Year
1
Fiscal Year
2001
Total Cost
Indirect Cost
Name
Alcohol Abuse and Alcoholism
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Turu, Gabor; Varnai, Peter; Gyombolai, Pal et al. (2009) Paracrine transactivation of the CB1 cannabinoid receptor by AT1 angiotensin and other Gq/11 protein-coupled receptors. J Biol Chem 284:16914-21
Jeong, Won-il; Osei-Hyiaman, Douglas; Park, Ogyi et al. (2008) Paracrine activation of hepatic CB1 receptors by stellate cell-derived endocannabinoids mediates alcoholic fatty liver. Cell Metab 7:227-35
Christ-Crain, Mirjam; Kola, Blerina; Lolli, Francesca et al. (2008) AMP-activated protein kinase mediates glucocorticoid-induced metabolic changes: a novel mechanism in Cushing's syndrome. FASEB J 22:1672-83
Palkovits, M; Harvey-White, J; Liu, J et al. (2008) Regional distribution and effects of postmortal delay on endocannabinoid content of the human brain. Neuroscience 152:1032-9
Liu, Jie; Wang, Lei; Harvey-White, Judith et al. (2008) Multiple pathways involved in the biosynthesis of anandamide. Neuropharmacology 54:1-7
Kunos, George (2008) A tribute to Dr. Ting-Kai Li. Alcohol Clin Exp Res 32:2030
Osei-Hyiaman, Douglas; Liu, Jie; Zhou, Liang et al. (2008) Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice. J Clin Invest 118:3160-9
Kunos, George; Osei-Hyiaman, Douglas (2008) Endocannabinoids and liver disease. IV. Endocannabinoid involvement in obesity and hepatic steatosis. Am J Physiol Gastrointest Liver Physiol 294:G1101-4
Kunos, George; Gao, Bin (2008) Endocannabinoids, CB1 receptors, and liver disease: hitting more than one bird with the same stone. Gastroenterology 134:622-5
Buettner, Christoph; Muse, Evan D; Cheng, Andrew et al. (2008) Leptin controls adipose tissue lipogenesis via central, STAT3-independent mechanisms. Nat Med 14:667-75

Showing the most recent 10 out of 31 publications